PL370978A1 - Pochodne benzotiazolu - Google Patents

Pochodne benzotiazolu

Info

Publication number: PL370978A1
Authority: PL; Poland
Prior art keywords: benzothiazole derivatives; benzothiazole; derivatives
Prior art date: 2001-11-27

Application number

PL02370978A

Other languages

English (en)

Inventor

Alexander Flohr

Roland Jakob-Roetne

Roger David Norcross

Claus Riemer

Original Assignee

F.Hoffmann-La Roche Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-11-27

Filing date

2002-11-18

Publication date

2005-06-13

2002-11-18 Application filed by F.Hoffmann-La Roche Ag filed Critical F.Hoffmann-La Roche Ag

2005-06-13 Publication of PL370978A1 publication Critical patent/PL370978A1/pl

Links

IOJUPLGTWVMSFF-UHFFFAOYSA-N benzothiazole Chemical class C1=CC=C2SC=NC2=C1 IOJUPLGTWVMSFF-UHFFFAOYSA-N 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles
- C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Pulmonology (AREA)
Pain & Pain Management (AREA)
Cardiology (AREA)
Psychiatry (AREA)
Heart & Thoracic Surgery (AREA)
Psychology (AREA)
Hospice & Palliative Care (AREA)
Anesthesiology (AREA)
Vascular Medicine (AREA)
Urology & Nephrology (AREA)
Toxicology (AREA)
Immunology (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Thiazole And Isothizaole Compounds (AREA)

PL02370978A 2001-11-27 2002-11-18 Pochodne benzotiazolu PL370978A1 (pl)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP01127442		2001-11-27

Publications (1)

Publication Number	Publication Date
PL370978A1 true PL370978A1 (pl)	2005-06-13

Family

ID=8179277

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL02370978A PL370978A1 (pl)	2001-11-27	2002-11-18	Pochodne benzotiazolu

Country Status (21)

Country	Link
US (1)	US6596718B1 (pl)
EP (1)	EP1450796B1 (pl)
JP (1)	JP4216193B2 (pl)
KR (1)	KR100613197B1 (pl)
CN (1)	CN1325052C (pl)
AR (1)	AR037418A1 (pl)
AT (1)	ATE391505T1 (pl)
AU (1)	AU2002352045B2 (pl)
BR (1)	BR0214455A (pl)
CA (1)	CA2467825A1 (pl)
DE (1)	DE60226063T2 (pl)
ES (1)	ES2303558T3 (pl)
GT (1)	GT200200240A (pl)
MX (1)	MXPA04004982A (pl)
PA (1)	PA8558201A1 (pl)
PE (1)	PE20030735A1 (pl)
PL (1)	PL370978A1 (pl)
RU (1)	RU2293083C2 (pl)
TW (1)	TW200408391A (pl)
UY (1)	UY27551A1 (pl)
WO (1)	WO2003045385A1 (pl)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2008011131A2 (en) *	2006-07-21	2008-01-24	Takeda Pharmaceutical Company Limited	Amide compounds
US6678828B1 (en) *	2002-07-22	2004-01-13	Vormetric, Inc.	Secure network file access control system
PT1636223E (pt)	2003-05-19	2008-05-06	F Hoffmann-La Roche Ag	Derivados de benzotiazole como ligandos de receptores da adenosina
WO2005033079A1 (ja) *	2003-09-30	2005-04-14	Eisai Co., Ltd.	ヘテロ環化合物を含有する新規な抗真菌剤
EP1677791A4 (en)	2003-10-31	2007-08-15	Takeda Pharmaceutical	NITROGENIC CONDENSED HETEROCYCLIC COMPOUNDS
EP1710233A4 (en) *	2004-01-28	2009-07-15	Kissei Pharmaceutical	NEW BENZO FURANDERIVATE, THIS MEDICAL COMPOSITION AND APPLICATIONS THEREOF
WO2005096098A2 (en) *	2004-03-30	2005-10-13	Carl Zeiss Smt Ag	Projection objective, projection exposure apparatus and reflective reticle for microlithography
CN1989117B (zh) *	2004-07-22	2011-01-19	弗·哈夫曼-拉罗切有限公司	取代的苯并噻唑
US20090227799A1 (en) *	2004-08-09	2009-09-10	Kazutaka Nakamoto	Novel Antimalarial Agent Containing Heterocyclic Compound
EP1864980A4 (en)	2005-03-30	2010-08-18	Eisai R&D Man Co Ltd	A PYRIDINE DERIVATIVE ANTIPILIC AGENT
WO2006115134A1 (ja) *	2005-04-22	2006-11-02	Kissei Pharmaceutical Co., Ltd.	新規なベンゾフラン誘導体、それを含有する医薬組成物およびそれらの用途
TWI385169B (zh) *	2005-10-31	2013-02-11	Eisai R&D Man Co Ltd	經雜環取代之吡啶衍生物及含有彼之抗真菌劑
EP2065377B1 (en) *	2006-09-21	2011-11-23	Eisai R&D Management Co., Ltd.	Pyridine derivative substituted by heteroaryl ring, and antifungal agent comprising the same
DE602007006990D1 (de)	2006-12-07	2010-07-15	Hoffmann La Roche	Spiropiperidinderivate als antagonisten des via-rezeptors
BRPI0721138A2 (pt)	2006-12-22	2014-04-01	Hoffmann La Roche	Derivados de espiro-piperidina
CN101563323B (zh)	2006-12-22	2012-07-04	弗·哈夫曼-拉罗切有限公司	螺-哌啶衍生物
TW200841879A (en)	2007-04-27	2008-11-01	Eisai R&D Man Co Ltd	Pyridine derivatives substituted by heterocyclic ring and phosphonoamino group, and anti-fungal agent containing same
WO2008136279A1 (ja) *	2007-04-27	2008-11-13	Eisai R & D Management Co., Ltd.	ヘテロ環置換ピリジン誘導体の塩またはその結晶
US8513287B2 (en)	2007-12-27	2013-08-20	Eisai R&D Management Co., Ltd.	Heterocyclic ring and phosphonoxymethyl group substituted pyridine derivatives and antifungal agent containing same
US8188119B2 (en) *	2008-10-24	2012-05-29	Eisai R&D Management Co., Ltd	Pyridine derivatives substituted with heterocyclic ring and γ-glutamylamino group, and antifungal agents containing same
EP2723718A1 (en)	2011-06-24	2014-04-30	Amgen Inc.	Trpm8 antagonists and their use in treatments
JP2014527511A (ja)	2011-06-24	2014-10-16	アムジエン・インコーポレーテツド	Ｔｒｐｍ８拮抗剤及び治療におけるそれらの使用
WO2013042137A1 (en) *	2011-09-19	2013-03-28	Aurigene Discovery Technologies Limited	Bicyclic heterocycles as irak4 inhibitors
US8940742B2 (en)	2012-04-10	2015-01-27	Infinity Pharmaceuticals, Inc.	Heterocyclic compounds and uses thereof
US8952009B2 (en)	2012-08-06	2015-02-10	Amgen Inc.	Chroman derivatives as TRPM8 inhibitors
US9751888B2 (en)	2013-10-04	2017-09-05	Infinity Pharmaceuticals, Inc.	Heterocyclic compounds and uses thereof
PT3052485T (pt)	2013-10-04	2021-10-22	Infinity Pharmaceuticals Inc	Compostos heterocíclicos e suas utilizações
MX382033B (es)	2014-03-19	2025-03-13	Infinity Pharmaceuticals Inc	Compuestos heterocíclicos para utilizarlos en el tratamiento de trastornos mediados por pi3k-gamma.
WO2016054491A1 (en)	2014-10-03	2016-04-07	Infinity Pharmaceuticals, Inc.	Heterocyclic compounds and uses thereof
WO2017048702A1 (en)	2015-09-14	2017-03-23	Infinity Pharmaceuticals, Inc.	Solid forms of isoquinolinone derivatives, process of making, compositions comprising, and methods of using the same
WO2017161116A1 (en)	2016-03-17	2017-09-21	Infinity Pharmaceuticals, Inc.	Isotopologues of isoquinolinone and quinazolinone compounds and uses thereof as pi3k kinase inhibitors
WO2017214269A1 (en)	2016-06-08	2017-12-14	Infinity Pharmaceuticals, Inc.	Heterocyclic compounds and uses thereof
AU2017360939B2 (en) *	2016-11-18	2022-03-03	Merck Sharp & Dohme Corp.	Indazole derivatives useful as inhibitors of diacylglyceride O-acyltransferase 2
WO2020048583A1 (en) *	2018-09-04	2020-03-12	F. Hoffmann-La Roche Ag	Benzothiazole compounds for the treatment of autoimmune diseases

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB8717068D0 (en) *	1987-07-20	1987-08-26	Fujisawa Pharmaceutical Co	Nitric ester derivative
AU2001281817B2 (en) *	2000-06-21	2005-11-24	F. Hoffmann-La Roche Ag	Benzothiazole derivatives

2002
- 2002-11-18 US US10/298,347 patent/US6596718B1/en not_active Expired - Fee Related
- 2002-11-18 RU RU2004119438/04A patent/RU2293083C2/ru not_active IP Right Cessation
- 2002-11-18 PL PL02370978A patent/PL370978A1/pl not_active Application Discontinuation
- 2002-11-18 AU AU2002352045A patent/AU2002352045B2/en not_active Ceased
- 2002-11-18 JP JP2003546887A patent/JP4216193B2/ja not_active Expired - Fee Related
- 2002-11-18 WO PCT/EP2002/012907 patent/WO2003045385A1/en not_active Ceased
- 2002-11-18 DE DE60226063T patent/DE60226063T2/de not_active Expired - Lifetime
- 2002-11-18 AT AT02787718T patent/ATE391505T1/de active
- 2002-11-18 CN CNB028236041A patent/CN1325052C/zh not_active Expired - Fee Related
- 2002-11-18 KR KR1020047007929A patent/KR100613197B1/ko not_active Expired - Fee Related
- 2002-11-18 ES ES02787718T patent/ES2303558T3/es not_active Expired - Lifetime
- 2002-11-18 EP EP02787718A patent/EP1450796B1/en not_active Expired - Lifetime
- 2002-11-18 CA CA002467825A patent/CA2467825A1/en not_active Abandoned
- 2002-11-18 MX MXPA04004982A patent/MXPA04004982A/es active IP Right Grant
- 2002-11-18 BR BR0214455-7A patent/BR0214455A/pt not_active IP Right Cessation
- 2002-11-22 PA PA20028558201A patent/PA8558201A1/es unknown
- 2002-11-22 GT GT200200240A patent/GT200200240A/es unknown
- 2002-11-22 TW TW091134083A patent/TW200408391A/zh unknown
- 2002-11-25 PE PE2002001132A patent/PE20030735A1/es not_active Application Discontinuation
- 2002-11-25 AR ARP020104516A patent/AR037418A1/es unknown
- 2002-11-26 UY UY27551A patent/UY27551A1/es not_active Application Discontinuation

Also Published As

Publication number	Publication date
EP1450796A1 (en)	2004-09-01
UY27551A1 (es)	2003-06-30
RU2004119438A (ru)	2006-01-10
MXPA04004982A (es)	2004-08-11
WO2003045385A1 (en)	2003-06-05
AU2002352045B2 (en)	2006-08-17
AR037418A1 (es)	2004-11-10
KR20040062968A (ko)	2004-07-09
CA2467825A1 (en)	2003-06-05
AU2002352045A1 (en)	2003-06-10
CN1325052C (zh)	2007-07-11
KR100613197B1 (ko)	2006-08-21
ATE391505T1 (de)	2008-04-15
DE60226063D1 (en)	2008-05-21
US6596718B1 (en)	2003-07-22
PE20030735A1 (es)	2003-08-29
JP2005526007A (ja)	2005-09-02
EP1450796B1 (en)	2008-04-09
DE60226063T2 (de)	2009-05-20
GT200200240A (es)	2003-07-30
ES2303558T3 (es)	2008-08-16
JP4216193B2 (ja)	2009-01-28
TW200408391A (en)	2004-06-01
CN1731999A (zh)	2006-02-08
RU2293083C2 (ru)	2007-02-10
PA8558201A1 (es)	2003-09-05
BR0214455A (pt)	2004-11-03

Legal Events

Date	Code	Title	Description
2011-08-31	REFS	Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)

Publication	Publication Date	Title
IL161623A0 (en)	2004-09-27	Nicotin-or isonicotin benzothiazole derivatives
PL370978A1 (pl)	2005-06-13	Pochodne benzotiazolu
IL153278A0 (en)	2003-07-06	Benzothiazole derivatives
EP1392664A4 (en)	2005-01-26	EPOTHILONE DERIVATIVES
IL160701A0 (en)	2004-08-31	3-substituted-4-pyrimidone derivatives
PL372123A1 (pl)	2005-07-11	Pochodne tiazolu
ZA200309522B (en)	2005-02-23	Substituted cyclohexane-1-4diamine derivatives
AP1850A (en)	2008-05-26	Spiroindolineplperidine derivatives
IL190341A0 (en)	2009-09-22	Heterocyclocarboxamide derivatives
EP1522540A4 (en)	2011-08-10	AZAARENE DERIVATIVES
PL376475A1 (pl)	2005-12-27	Pochodne N-podstawionej 2-oksodihydropirydyny
IL158388A0 (en)	2004-05-12	Novel arylheteroalkylamine derivatives
IL166426A0 (en)	2006-01-15	N-biarylmethyl aminocycloalkanecarboxamide derivatives
HUP0303449A3 (en)	2005-02-28	Substituted benzofuran-2-carboxamides derivatives
PL375416A1 (pl)	2005-11-28	Pochodne tiazolu
HUP0303186A3 (en)	2007-06-28	4-aminobenzopyran derivatives
HUP0401949A3 (en)	2009-07-28	4-imidazolin-2-one derivatives
HUP0500026A3 (en)	2008-02-28	N-heteroarylnicotinamide derivatives
AU2003222659A8 (en)	2003-11-03	23-o-substituted 5-o-mycaminosyltylonide derivatives
PL373947A1 (pl)	2005-09-19	Pochodne benzotiazolu
AU2003294938A8 (en)	2004-07-14	Epothilone derivatives
DE60207294D1 (en)	2005-12-15	Benzothiazole
IL159064A0 (en)	2004-05-12	New phenylalkyloxy- phenyl derivatives
EP1364954A4 (en)	2009-10-28	Dicarba closo DODECARBORANDERIVATE
EP1531854A4 (en)	2006-06-28	O-DERIVATED NOCATHIACIN DERIVATIVES